Role of leukotrienes and leukotriene receptor antagonist in asthma: new advances
Rodger, I.W.
Journal of Investigational Allergology and Clinical Immunology 7(5): 279
1997
ISSN/ISBN: 1018-9068 PMID: 9416517 Document Number: 472861
Document emailed within 1 workday
Related Documents
Kupryś, I.; Kuna, P. 2000: The role of leukotrienes and the effect of leukotriene receptor antagonists in allergic rhinitis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 9(52): 717-720Klingman, D.; Bielory, L.; Wang, Y.; Silverman, S.; Bell, C.F.; Joy, K.A.; Dever, M.T.; Jones, D.A. 2001: Asthma outcome changes associated with use of the leukotriene-receptor antagonist zafirlukast Managed Care Interface 14(2): 62-66
Vega López, M.; Jiménez Ferral, R. 2001: Experience with montelukast, a leukotriene receptor antagonist, in pediatric patients with asthma Revista Alergia Mexico 48(5): 133-136
Mong, S.; Wu, H.L.; Miller, J.; Hall, R.F.; Gleason, J.G.; Crooke, S.T. 1987: SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4 Molecular Pharmacology 32(1): 223-229
Woszczek, G.; Chen, L-Yuan.; Nagineni, S.; Alsaaty, S.; Harry, A.; Logun, C.; Pawliczak, R.; Shelhamer, J.H. 2007: IFN-gamma induces cysteinyl leukotriene receptor 2 expression and enhances the responsiveness of human endothelial cells to cysteinyl leukotrienes Journal of Immunology 178(8): 5262-5270
Krausz, M.M.; Dahan, J.B.; Gross, D. 1988: Effect of the leukotriene receptor antagonist LY-171883 on endotoxemia in awake sheep Circulatory Shock 26(4): 431-441
Fabbri, L.; Caramori, G.; Beghè, B.; Ciaccia, A. 1996: Role of leukotrienes in asthma pathogenesis Monaldi Archives for Chest Disease 51(6): 548-555
Hirano, T. 1997: Peptide leukotriene receptor antagonist diminishes pancreatic edema formation in rats with cerulein-induced acute pancreatitis Scandinavian Journal of Gastroenterology 32(1): 84-88
Bjermer, L.; Diamant, Z. 2002: The use of leukotriene receptor antagonists (LTRAs) as complementary therapy in asthma Monaldi Archives for Chest Disease 57(1): 76-83
Kohno, S. 1998: Role of peptide-leukotrienes in bronchial asthma Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 111(4): 223-231
Tsuchida, T.; Matsuse, H.; Machida, I.; Kondo, Y.; Saeki, S.; Tomari, S.; Obase, Y.; Matsuo, N.; Shimoda, T.; Kohno, S. 2005: Evaluation of theophylline or pranlukast, a cysteinyl leukotriene receptor 1 antagonist, as add-on therapy in uncontrolled asthmatic patients with a medium dose of inhaled corticosteroids Allergy and Asthma Proceedings 26(4): 287-291
Tashkin, D.P. 2001: The importance of control in asthma management: do leukotriene receptor antagonists meet patient and physician needs? Allergy and Asthma Proceedings 22(5): 311-319
Bu, X.; Wang, C.; Pang, B. 2003: Effects of leukotriene receptor antagonist on chronic obstructive [correction of obstractive] pulmonary disease induced pulmonary hypertension Chinese Medical Journal 116(3): 459-461
Salazar Villa, R.M.; Zambrano Villa, S. 1994: Asthma induced by aspirin and arachidonic acid metabolites. Role of leukotrienes (third part) Revista Alergia Mexico 41(2): 51-57
Hullot, P.; Poudrel, J.M.; Muller, A.; Escale, R.; Rossi, J.C.; Girard, J.P.; Bonne, C. 1997: Synthesis and biochemical/pharmacological profile of the novel leukotriene B4 receptor antagonist sodium (1S*, 3S*)-1-hydroxy-3-[(3 R*S*,E)-3-hydroxy-7-phenyl-1-hepten-1-yl]-1-cyclohexane acetate Arzneimittel-Forschung 47(1): 51-58
Karaulov, A.V.; Silvestrov, V.P.; Pomoĭnetskiĭ, V.D.; Zakharov, V.N.; Masenko, V.P. 1986: Role of the eicosanoids: prostaglandins, prostacyclin, thromboxane and leukotrienes in the pathogenesis of bronchial asthma and other lung diseases Terapevticheskii Arkhiv 58(3): 123-130
Kuperman, A.V.; Kalgutkar, A.S.; Marfat, A.; Chambers, R.J.; Liston, T.E. 2001: Pharmacokinetics and metabolism of a cysteinyl leukotriene-1 receptor antagonist from the heterocyclic chromanol series in rats: in vitro-in vivo correlation, gender-related differences, isoform identification, and comparison with metabolism in human hepatic tissue Drug Metabolism and Disposition: the Biological Fate of Chemicals 29(11): 1403-1409
Gabay, C.; Porter, B.; Fantuzzi, G.; Arend, W.P. 1998: Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo Journal of Immunology 159(12): 5905-5913
Sehouli, J.; Mustea, A.; Könsgen, D.; Katsares, I.; Lichtenegger, W. 2002: Polymorphism of IL-1 receptor antagonist gene: role in cancer Anticancer Research 22(6a): 3421-3424
Cook, J.A.; Wise, W.C.; Halushka, P.V. 1985: Protective effect of a selective leukotriene antagonist in endotoxemia in the rat Journal of Pharmacology and Experimental Therapeutics 235(2): 470-474